Webinar Scheduled About Contrast Management for Myopia Control

Wednesday, April 8 2026 | 08 h 00 min | News

Canadian eye care professionals are invited to attend an educational webinar examining the growing evidence base for contrast management as a method for slowing myopia progression in children. On April 15 at 6 p.m. PT (9 p.m. ET), SightGlass Vision will host “Unlocking the Power of Contrast Management: Real-World Results with MiSight^® Spectacle Lenses Powered by Diffusion Optics Technology™.” 

The session will feature Fabio Carta, Dip. Optom, FBCLA, Director of Professional Affairs at SightGlass Vision, and Dr. Kylvin Ho, Optometrist, FIAOMC, of C U Vision Optometrists in Vancouver, a leading myopia control optometrist.

Canadian eye care professionals interested in attending the webinar can register here.

The webinar will explore how managing contrast works to help control myopia, bridging the underlying science with practical application in clinical care. Carta will introduce eye care professionals to DOT™ spectacle lenses—available in Canada as MiSight^® Spectacle Lenses powered by Diffusion Optics Technology™—the first myopia management treatment specifically designed to reduce retinal contrast signaling through the incorporation of light scattering elements.^[1] He will also review clinical research showing that the lenses can slow myopia progression by up to 75% after 12 months of wear across diverse patient populations.^1,[2]*

Dr. Ho will then share real-world clinical cases from his experience prescribing the lenses in practice, providing a peer-to-peer perspective into how the lenses are helping his patients. The session will conclude with a Q&A for attendees.

For more information on the April 15 webinar, visit the registration page.

 *Patient population aged 6–10 years (CYPRESS) and 6–13 years (CATHAY). Prescribed DOT lens wear time was 10 hours per day.

---

^[1] Rappon et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study. Br J Ophthalmol. 2023;107:1709-1715.

^[2] Laughton et al. Control of myopia using contrast modulation spectacle lenses in a Chinese population: 12-month results. Invest. Ophthalmol. Vis. Sci. 2025;66(8):2815.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!